PUTRAJAYA: It will take up to four months for the National Pharmaceutical Regulatory Agency (NPRA) to evaluate the clinical trial data provided by pharmaceutical giant Pfizer on the Covid-19 vaccine it has developed.
Health director-general Tan Sri Dr Noor Hisham Abdullah said the NPRA received a formal application from Pfizer on Dec 15 to have its Covid-19 vaccine registered in Malaysia.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
